CA2511128C - Late-pcr - Google Patents
Late-pcr Download PDFInfo
- Publication number
- CA2511128C CA2511128C CA2511128A CA2511128A CA2511128C CA 2511128 C CA2511128 C CA 2511128C CA 2511128 A CA2511128 A CA 2511128A CA 2511128 A CA2511128 A CA 2511128A CA 2511128 C CA2511128 C CA 2511128C
- Authority
- CA
- Canada
- Prior art keywords
- primer
- concentration
- pcr
- excess
- limiting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000523 sample Substances 0.000 claims abstract description 390
- 238000002844 melting Methods 0.000 claims abstract description 240
- 230000008018 melting Effects 0.000 claims abstract description 237
- 230000000670 limiting effect Effects 0.000 claims abstract description 199
- 230000003321 amplification Effects 0.000 claims abstract description 167
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 167
- 108091093088 Amplicon Proteins 0.000 claims abstract description 143
- 238000003556 assay Methods 0.000 claims abstract description 117
- 238000009396 hybridization Methods 0.000 claims abstract description 111
- 238000000034 method Methods 0.000 claims abstract description 102
- 238000001514 detection method Methods 0.000 claims abstract description 98
- 238000003752 polymerase chain reaction Methods 0.000 claims abstract description 23
- 239000013615 primer Substances 0.000 claims description 965
- 238000006243 chemical reaction Methods 0.000 claims description 241
- 238000000137 annealing Methods 0.000 claims description 106
- 108020004414 DNA Proteins 0.000 claims description 79
- 102000053602 DNA Human genes 0.000 claims description 79
- 108091034117 Oligonucleotide Proteins 0.000 claims description 79
- 108700028369 Alleles Proteins 0.000 claims description 55
- 230000000295 complement effect Effects 0.000 claims description 51
- 239000011541 reaction mixture Substances 0.000 claims description 51
- 238000012408 PCR amplification Methods 0.000 claims description 45
- 150000007523 nucleic acids Chemical class 0.000 claims description 42
- 102000039446 nucleic acids Human genes 0.000 claims description 27
- 108020004707 nucleic acids Proteins 0.000 claims description 27
- 229920002477 rna polymer Polymers 0.000 claims description 20
- 239000003153 chemical reaction reagent Substances 0.000 claims description 19
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 18
- 230000001351 cycling effect Effects 0.000 claims description 18
- 230000035772 mutation Effects 0.000 claims description 13
- 239000002987 primer (paints) Substances 0.000 claims description 13
- 238000005382 thermal cycling Methods 0.000 claims description 13
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 12
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 12
- 239000007850 fluorescent dye Substances 0.000 claims description 11
- 238000007837 multiplex assay Methods 0.000 claims description 9
- 230000037452 priming Effects 0.000 claims description 9
- 230000009977 dual effect Effects 0.000 claims description 8
- 239000005547 deoxyribonucleotide Substances 0.000 claims description 6
- 230000002441 reversible effect Effects 0.000 claims description 6
- 230000004544 DNA amplification Effects 0.000 claims description 5
- -1 deoxyribonucleotide triphosphates Chemical class 0.000 claims description 5
- 239000001226 triphosphate Substances 0.000 claims description 5
- 235000011178 triphosphate Nutrition 0.000 claims description 5
- 239000003155 DNA primer Substances 0.000 claims description 4
- 238000003306 harvesting Methods 0.000 claims description 4
- 238000011897 real-time detection Methods 0.000 claims description 3
- 239000000047 product Substances 0.000 description 130
- 210000004027 cell Anatomy 0.000 description 70
- 238000002944 PCR assay Methods 0.000 description 29
- 201000003883 Cystic fibrosis Diseases 0.000 description 26
- 108090000623 proteins and genes Proteins 0.000 description 26
- 125000003729 nucleotide group Chemical group 0.000 description 24
- 239000000203 mixture Substances 0.000 description 23
- 239000002773 nucleotide Substances 0.000 description 23
- 230000015572 biosynthetic process Effects 0.000 description 22
- 238000004458 analytical method Methods 0.000 description 20
- 238000013461 design Methods 0.000 description 20
- 238000003786 synthesis reaction Methods 0.000 description 19
- 238000012360 testing method Methods 0.000 description 17
- 239000011534 wash buffer Substances 0.000 description 15
- 230000003247 decreasing effect Effects 0.000 description 14
- 210000001109 blastomere Anatomy 0.000 description 13
- 239000000872 buffer Substances 0.000 description 13
- 239000000975 dye Substances 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 210000001161 mammalian embryo Anatomy 0.000 description 12
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 12
- 239000002299 complementary DNA Substances 0.000 description 11
- 238000001917 fluorescence detection Methods 0.000 description 11
- 238000012546 transfer Methods 0.000 description 10
- 230000008901 benefit Effects 0.000 description 9
- 238000001574 biopsy Methods 0.000 description 9
- 230000007423 decrease Effects 0.000 description 9
- 210000002257 embryonic structure Anatomy 0.000 description 9
- 238000003753 real-time PCR Methods 0.000 description 9
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 8
- 238000007846 asymmetric PCR Methods 0.000 description 8
- 230000008859 change Effects 0.000 description 8
- 238000003745 diagnosis Methods 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 238000009825 accumulation Methods 0.000 description 7
- 238000004364 calculation method Methods 0.000 description 7
- 150000001768 cations Chemical class 0.000 description 7
- 238000003366 endpoint assay Methods 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 7
- 230000035945 sensitivity Effects 0.000 description 7
- 101150029409 CFTR gene Proteins 0.000 description 6
- 108020004682 Single-Stranded DNA Proteins 0.000 description 6
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 6
- 238000004590 computer program Methods 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 6
- 230000002068 genetic effect Effects 0.000 description 6
- 102100022548 Beta-hexosaminidase subunit alpha Human genes 0.000 description 5
- 102000012605 Cystic Fibrosis Transmembrane Conductance Regulator Human genes 0.000 description 5
- 108010079245 Cystic Fibrosis Transmembrane Conductance Regulator Proteins 0.000 description 5
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 5
- 108010006785 Taq Polymerase Proteins 0.000 description 5
- 208000022292 Tay-Sachs disease Diseases 0.000 description 5
- 230000003466 anti-cipated effect Effects 0.000 description 5
- 239000011777 magnesium Substances 0.000 description 5
- 229910052749 magnesium Inorganic materials 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 229910052697 platinum Inorganic materials 0.000 description 5
- 230000035935 pregnancy Effects 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- 239000012807 PCR reagent Substances 0.000 description 4
- 238000011109 contamination Methods 0.000 description 4
- 238000004925 denaturation Methods 0.000 description 4
- 230000036425 denaturation Effects 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 210000001840 diploid cell Anatomy 0.000 description 4
- 210000003754 fetus Anatomy 0.000 description 4
- 210000005260 human cell Anatomy 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000000376 reactant Substances 0.000 description 4
- 230000010076 replication Effects 0.000 description 4
- 238000010839 reverse transcription Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 4
- 239000003298 DNA probe Substances 0.000 description 3
- 102100034343 Integrase Human genes 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 3
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 230000006037 cell lysis Effects 0.000 description 3
- 230000003111 delayed effect Effects 0.000 description 3
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000001502 gel electrophoresis Methods 0.000 description 3
- 230000000977 initiatory effect Effects 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 238000009830 intercalation Methods 0.000 description 3
- 239000000155 melt Substances 0.000 description 3
- 239000002751 oligonucleotide probe Substances 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 101100020619 Arabidopsis thaliana LATE gene Proteins 0.000 description 2
- 108020004635 Complementary DNA Proteins 0.000 description 2
- 241001633942 Dais Species 0.000 description 2
- AHCYMLUZIRLXAA-SHYZEUOFSA-N Deoxyuridine 5'-triphosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 AHCYMLUZIRLXAA-SHYZEUOFSA-N 0.000 description 2
- 108091027305 Heteroduplex Proteins 0.000 description 2
- 101710163270 Nuclease Proteins 0.000 description 2
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 2
- 241000239226 Scorpiones Species 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 238000003149 assay kit Methods 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- 239000006172 buffering agent Substances 0.000 description 2
- 238000010804 cDNA synthesis Methods 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 238000005251 capillar electrophoresis Methods 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000008004 cell lysis buffer Substances 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 2
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 2
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 2
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 2
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 238000005553 drilling Methods 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 238000012933 kinetic analysis Methods 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 239000002853 nucleic acid probe Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 238000003793 prenatal diagnosis Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 229940083575 sodium dodecyl sulfate Drugs 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 101150075675 tatC gene Proteins 0.000 description 2
- 238000010257 thawing Methods 0.000 description 2
- 125000002264 triphosphate group Chemical group [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 2
- 241000701161 unidentified adenovirus Species 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- WCKQPPQRFNHPRJ-UHFFFAOYSA-N 4-[[4-(dimethylamino)phenyl]diazenyl]benzoic acid Chemical compound C1=CC(N(C)C)=CC=C1N=NC1=CC=C(C(O)=O)C=C1 WCKQPPQRFNHPRJ-UHFFFAOYSA-N 0.000 description 1
- 241001447233 Arganthomyza duplex Species 0.000 description 1
- 241000182988 Assa Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 102000011045 Chloride Channels Human genes 0.000 description 1
- 108010062745 Chloride Channels Proteins 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 108020004394 Complementary RNA Proteins 0.000 description 1
- 108020003215 DNA Probes Proteins 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102100036243 HLA class II histocompatibility antigen, DQ alpha 1 chain Human genes 0.000 description 1
- 108010086786 HLA-DQA1 antigen Proteins 0.000 description 1
- 108091005904 Hemoglobin subunit beta Proteins 0.000 description 1
- 208000028782 Hereditary disease Diseases 0.000 description 1
- 102100036269 Hexosaminidase D Human genes 0.000 description 1
- 101001033280 Homo sapiens Cytokine receptor common subunit beta Proteins 0.000 description 1
- 101000899111 Homo sapiens Hemoglobin subunit beta Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 208000024556 Mendelian disease Diseases 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 102000006943 Uracil-DNA Glycosidase Human genes 0.000 description 1
- 108010072685 Uracil-DNA Glycosidase Proteins 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000002669 amniocentesis Methods 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 208000005980 beta thalassemia Diseases 0.000 description 1
- 108010085377 beta-N-Acetylhexosaminidases Proteins 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000003184 complementary RNA Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 210000001771 cumulus cell Anatomy 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 230000000368 destabilizing effect Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000007847 digital PCR Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 102000034356 gene-regulatory proteins Human genes 0.000 description 1
- 108091006104 gene-regulatory proteins Proteins 0.000 description 1
- 230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 description 1
- 238000003205 genotyping method Methods 0.000 description 1
- 108060003196 globin Proteins 0.000 description 1
- 102000055647 human CSF2RB Human genes 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000007403 mPCR Methods 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- 238000007857 nested PCR Methods 0.000 description 1
- 208000012978 nondisjunction Diseases 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000036647 reaction Effects 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6851—Quantitative amplification
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
- Debugging And Monitoring (AREA)
- Separation By Low-Temperature Treatments (AREA)
- Sampling And Sample Adjustment (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Underground Structures, Protecting, Testing And Restoring Foundations (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34188601P | 2001-12-19 | 2001-12-19 | |
| US60/341,886 | 2001-12-19 | ||
| US10/320,893 US7198897B2 (en) | 2001-12-19 | 2002-12-17 | Late-PCR |
| US10/320,893 | 2002-12-17 | ||
| PCT/US2002/040752 WO2003054233A1 (en) | 2001-12-19 | 2002-12-19 | Late-pcr |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2511128A1 CA2511128A1 (en) | 2003-07-03 |
| CA2511128C true CA2511128C (en) | 2011-01-18 |
Family
ID=26982708
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2511128A Expired - Fee Related CA2511128C (en) | 2001-12-19 | 2002-12-19 | Late-pcr |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US7198897B2 (enExample) |
| EP (1) | EP1468114B1 (enExample) |
| JP (1) | JP4355211B2 (enExample) |
| AT (1) | ATE394508T1 (enExample) |
| AU (1) | AU2002360685A1 (enExample) |
| CA (1) | CA2511128C (enExample) |
| DE (1) | DE60226500D1 (enExample) |
| DK (1) | DK1468114T3 (enExample) |
| ES (1) | ES2306807T3 (enExample) |
| PT (1) | PT1468114E (enExample) |
| WO (1) | WO2003054233A1 (enExample) |
Families Citing this family (127)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003021259A1 (en) * | 2001-09-05 | 2003-03-13 | Perlegen Sciences, Inc. | Selection of primer pairs |
| EP1594950A4 (en) | 2003-01-29 | 2007-07-25 | 454 Corp | PRODUCT FOR THE PREPARATION OF SIMPLE STRANDED DNA BANKS |
| EP1454994A1 (en) * | 2003-03-07 | 2004-09-08 | Université de la Méditerranée | Standardized and optimized real-time quantitative reverse transcriptase polymerase chain reaction method for detection of MRD in leukemia |
| US7041481B2 (en) | 2003-03-14 | 2006-05-09 | The Regents Of The University Of California | Chemical amplification based on fluid partitioning |
| US8679789B2 (en) | 2003-05-01 | 2014-03-25 | Gen-Probe Incorporated | Oligonucleotides comprising a molecular switch |
| EP1631685B1 (en) * | 2003-05-19 | 2010-12-29 | Brandeis University | Nucleic acid processing methods, kits and devices |
| CA2531105C (en) * | 2003-07-05 | 2015-03-17 | The Johns Hopkins University | Method and compositions for detection and enumeration of genetic variations |
| WO2005073410A2 (en) * | 2004-01-28 | 2005-08-11 | 454 Corporation | Nucleic acid amplification with continuous flow emulsion |
| JP4455168B2 (ja) * | 2004-05-31 | 2010-04-21 | 株式会社ニチレイフーズ | Ｄｎａ増幅方法 |
| US20060057611A1 (en) * | 2004-06-30 | 2006-03-16 | Applera Corporation | Log-linear amplification |
| JP2006055065A (ja) * | 2004-08-19 | 2006-03-02 | Toyo Kohan Co Ltd | 非対称ｐｃｒを用いた核酸の検出方法、ポリヌクレオチドプローブ、それを固定するプローブ固定化担体およびキット |
| CN1280422C (zh) * | 2004-08-26 | 2006-10-18 | 北京博奥生物芯片有限责任公司 | 一种不对称pcr扩增方法及其应用 |
| NZ554701A (en) | 2004-10-18 | 2010-03-26 | Univ Brandeis | Reagents and methods for improving reproducibility and reducing mispriming in PCR amplification |
| RU2460804C2 (ru) * | 2004-10-18 | 2012-09-10 | Брандейс Юнивесити | Способ гомогенной детекции по меньшей мере одного продукта одноцепочечной амплификации |
| WO2006053259A2 (en) * | 2004-11-12 | 2006-05-18 | Transgenomic, Inc. | Fluorescent mutation detection with mismatch cutting dna endonucleases |
| AU2006272568B2 (en) | 2005-07-26 | 2012-06-28 | Merck Sharp & Dohme Corp. | Assays for resistance to echinocandin-class drugs |
| US9424392B2 (en) | 2005-11-26 | 2016-08-23 | Natera, Inc. | System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals |
| US11111544B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
| US8637436B2 (en) | 2006-08-24 | 2014-01-28 | California Institute Of Technology | Integrated semiconductor bioarray |
| US11001881B2 (en) | 2006-08-24 | 2021-05-11 | California Institute Of Technology | Methods for detecting analytes |
| BRPI0712655A2 (pt) * | 2006-06-08 | 2012-11-20 | Koninkl Philips Electronics Nv | dispositivo de sensor microeletrânico, mÉtodo para investigaÇço de pelo menos uma substÂncia alvo biolàgica, e, uso do dispositivo de sensor microeletrânico |
| US7972786B2 (en) * | 2006-07-07 | 2011-07-05 | Brandeis University | Detection and analysis of influenza virus |
| AU2007275762B2 (en) | 2006-07-17 | 2012-02-23 | Brandeis University | Specialized oligonucleotides and their use in nucleic acid amplification and detection |
| US7501254B2 (en) | 2006-07-20 | 2009-03-10 | Ghc Technologies, Inc. | Methods and compositions for amplification and capture of nucleic acid sequences |
| WO2008014485A2 (en) | 2006-07-28 | 2008-01-31 | California Institute Of Technology | Multiplex q-pcr arrays |
| US11525156B2 (en) | 2006-07-28 | 2022-12-13 | California Institute Of Technology | Multiplex Q-PCR arrays |
| US11560588B2 (en) | 2006-08-24 | 2023-01-24 | California Institute Of Technology | Multiplex Q-PCR arrays |
| JP2008154467A (ja) * | 2006-12-21 | 2008-07-10 | Olympus Corp | 核酸の増幅方法とこれを用いた核酸の解析方法 |
| CN101903535A (zh) * | 2007-03-28 | 2010-12-01 | 信号诊断公司 | 高解析度分析核酸以检测序列变异的系统和方法 |
| JP2009148245A (ja) * | 2007-06-12 | 2009-07-09 | Toyobo Co Ltd | 核酸の迅速な検出方法 |
| GB0720264D0 (en) * | 2007-10-17 | 2007-11-28 | Smiths Detection Watford Ltd | Sample preparation devices and analyzers |
| MX2010005060A (es) * | 2007-11-08 | 2010-07-05 | Univ Washington | Identificacion y mapeo a base de microarreglos de adn de puntos de ruptura de translocacion equilibrados. |
| EP2138588A1 (en) * | 2008-06-23 | 2009-12-30 | Koninklijke Philips Electronics N.V. | Melting curve measurement during amplification |
| US8173401B2 (en) | 2008-06-30 | 2012-05-08 | Life Technologies Coporation | Method for direct amplification from crude nucleic acid samples |
| US12090480B2 (en) | 2008-09-23 | 2024-09-17 | Bio-Rad Laboratories, Inc. | Partition-based method of analysis |
| US9417190B2 (en) | 2008-09-23 | 2016-08-16 | Bio-Rad Laboratories, Inc. | Calibrations and controls for droplet-based assays |
| US10512910B2 (en) | 2008-09-23 | 2019-12-24 | Bio-Rad Laboratories, Inc. | Droplet-based analysis method |
| US9399215B2 (en) | 2012-04-13 | 2016-07-26 | Bio-Rad Laboratories, Inc. | Sample holder with a well having a wicking promoter |
| US12162008B2 (en) | 2008-09-23 | 2024-12-10 | Bio-Rad Laboratories, Inc. | Partition-based method of analysis |
| CA2738578C (en) | 2008-09-23 | 2021-05-04 | Quantalife, Inc. | Droplet-based assay system |
| US9492797B2 (en) | 2008-09-23 | 2016-11-15 | Bio-Rad Laboratories, Inc. | System for detection of spaced droplets |
| US9156010B2 (en) | 2008-09-23 | 2015-10-13 | Bio-Rad Laboratories, Inc. | Droplet-based assay system |
| US8709762B2 (en) | 2010-03-02 | 2014-04-29 | Bio-Rad Laboratories, Inc. | System for hot-start amplification via a multiple emulsion |
| US9598725B2 (en) | 2010-03-02 | 2017-03-21 | Bio-Rad Laboratories, Inc. | Emulsion chemistry for encapsulated droplets |
| WO2011120006A1 (en) | 2010-03-25 | 2011-09-29 | Auantalife, Inc. A Delaware Corporation | Detection system for droplet-based assays |
| US9132394B2 (en) | 2008-09-23 | 2015-09-15 | Bio-Rad Laboratories, Inc. | System for detection of spaced droplets |
| US8951939B2 (en) | 2011-07-12 | 2015-02-10 | Bio-Rad Laboratories, Inc. | Digital assays with multiplexed detection of two or more targets in the same optical channel |
| US11130128B2 (en) | 2008-09-23 | 2021-09-28 | Bio-Rad Laboratories, Inc. | Detection method for a target nucleic acid |
| US8663920B2 (en) | 2011-07-29 | 2014-03-04 | Bio-Rad Laboratories, Inc. | Library characterization by digital assay |
| US9764322B2 (en) | 2008-09-23 | 2017-09-19 | Bio-Rad Laboratories, Inc. | System for generating droplets with pressure monitoring |
| US8633015B2 (en) * | 2008-09-23 | 2014-01-21 | Bio-Rad Laboratories, Inc. | Flow-based thermocycling system with thermoelectric cooler |
| US10669574B2 (en) | 2008-11-18 | 2020-06-02 | XCR Diagnostics, Inc. | DNA amplification technology |
| US8206929B2 (en) * | 2009-01-07 | 2012-06-26 | Roche Molecular Systems, Inc. | Nucleic acid amplification with allele-specific suppression of sequence variants |
| US9542526B2 (en) * | 2009-03-10 | 2017-01-10 | Canon U.S. Life Sciences, Inc. | Method and system for temperature correction in thermal melt analysis |
| EP2406394B1 (en) | 2009-03-12 | 2014-01-08 | Brandeis University | Reagents and methods for pcr |
| CA2768391C (en) | 2009-07-21 | 2016-09-06 | Gen-Probe Incorporated | Methods and compositions for quantitative detection of nucleic acid sequences over an extended dynamic range |
| AR077840A1 (es) * | 2009-08-11 | 2011-09-28 | Univ Brandeis | Ensayos de deteccion e identificacion de especies y tipos de staphylococcus |
| AR077841A1 (es) | 2009-08-11 | 2011-09-28 | Univ Brandeis | Metodos kits y composiciones de deteccion de acido nucleico a multiples temperaturas, con sonda unica |
| EP2473618B1 (en) | 2009-09-02 | 2015-03-04 | Bio-Rad Laboratories, Inc. | System for mixing fluids by coalescence of multiple emulsions |
| EP2491144B1 (en) | 2009-10-21 | 2015-09-30 | Brandeis University | Methods for analyzing single-stranded nucleic acid sequences |
| EP2550528B1 (en) | 2010-03-25 | 2019-09-11 | Bio-Rad Laboratories, Inc. | Droplet generation for droplet-based assays |
| EP2556170A4 (en) | 2010-03-25 | 2014-01-01 | Quantalife Inc | TRAPPING TRANSPORT AND DETECTION SYSTEM |
| US20190010543A1 (en) | 2010-05-18 | 2019-01-10 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US11322224B2 (en) | 2010-05-18 | 2022-05-03 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| US11332785B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| US9677118B2 (en) | 2014-04-21 | 2017-06-13 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US11339429B2 (en) | 2010-05-18 | 2022-05-24 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| US12221653B2 (en) | 2010-05-18 | 2025-02-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US11326208B2 (en) | 2010-05-18 | 2022-05-10 | Natera, Inc. | Methods for nested PCR amplification of cell-free DNA |
| US10316362B2 (en) | 2010-05-18 | 2019-06-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US11408031B2 (en) | 2010-05-18 | 2022-08-09 | Natera, Inc. | Methods for non-invasive prenatal paternity testing |
| US12152275B2 (en) | 2010-05-18 | 2024-11-26 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| US11332793B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US11939634B2 (en) | 2010-05-18 | 2024-03-26 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US8825412B2 (en) | 2010-05-18 | 2014-09-02 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| IT1405994B1 (it) * | 2010-06-22 | 2014-02-06 | Euroclone Spa | Metodo ad elevata sensibilita' per rilevare un acido nucleico target in un campione |
| WO2012023054A2 (en) | 2010-08-17 | 2012-02-23 | Smiths Detection-Watford Ltd. | Ndm-1 polymerase chain reaction (pcr) assay |
| EP2614157A4 (en) | 2010-09-08 | 2014-03-26 | Univ Brandeis | Compositions and methods for nucleic acid based diagnostic assays for variable sequence targets |
| US20130295570A1 (en) * | 2010-10-07 | 2013-11-07 | Brandeis University | Compositions and methods for nucleic acid based diagnostic assays |
| EP4016086A1 (en) | 2010-11-01 | 2022-06-22 | Bio-Rad Laboratories, Inc. | System for forming emulsions |
| ES2606145T3 (es) | 2010-11-10 | 2017-03-22 | Brandeis University | Procedimientos y kits para la detección e identificación de micobacterias |
| US9637790B2 (en) | 2010-12-03 | 2017-05-02 | Brandeis University | Detecting mutations in DNA |
| US9169514B2 (en) | 2010-12-03 | 2015-10-27 | Brandeis University | Detecting nucleic acid variations within populations of genomes |
| CA2965074A1 (en) * | 2010-12-27 | 2012-07-05 | Abbott Molecular Inc. | Quantitating high titer samples by digital pcr |
| WO2012095748A2 (en) | 2011-01-14 | 2012-07-19 | Smiths Detection - Watford Limited | Single tube quantitative polymerase chain reaction (pcr) |
| CA2824387C (en) | 2011-02-09 | 2019-09-24 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| US12097495B2 (en) | 2011-02-18 | 2024-09-24 | Bio-Rad Laboratories, Inc. | Methods and compositions for detecting genetic material |
| WO2012129187A1 (en) | 2011-03-18 | 2012-09-27 | Bio-Rad Laboratories, Inc. | Multiplexed digital assays with combinatorial use of signals |
| WO2012149042A2 (en) | 2011-04-25 | 2012-11-01 | Bio-Rad Laboratories, Inc. | Methods and compositions for nucleic acid analysis |
| AU2012312169B2 (en) | 2011-09-21 | 2016-01-14 | Gen-Probe Incorporated | Methods for amplifying nucleic acid using tag-mediated displacement |
| US9121051B2 (en) | 2011-10-31 | 2015-09-01 | Arkray, Inc. | Method of determining the abundance of a target nucleotide sequence of a gene of interest |
| JP5570657B2 (ja) | 2011-10-31 | 2014-08-13 | アークレイ株式会社 | 遺伝子存在量の測定方法 |
| WO2013122453A1 (en) * | 2012-02-15 | 2013-08-22 | Universiti Sains Malaysia | Device and method for detection of nucleic acid(s) |
| US20140100126A1 (en) | 2012-08-17 | 2014-04-10 | Natera, Inc. | Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data |
| EP2920326A1 (en) * | 2012-11-15 | 2015-09-23 | Molecular Detection Israel Ltd. | Pcr reaction mixtures and methods of using same |
| KR102222546B1 (ko) | 2013-02-07 | 2021-03-08 | 러트거즈,더스테이트유니버시티오브뉴저지 | 고도로 선택적인 핵산 증폭 프라이머 |
| US10752954B2 (en) * | 2013-03-14 | 2020-08-25 | The Trustees Of The University Of Pennsylvania | Method for detecting mutations in single cells or single molecules |
| CN105378160B (zh) * | 2013-08-12 | 2018-04-17 | 伯乐生命医学产品有限公司 | 具有碱基配对的寡聚体的扩增报告子 |
| ES2925313T3 (es) | 2013-10-09 | 2022-10-14 | Fluoresentric Inc | Método para la detección de secuencias de ácido nucleico diana |
| PT3089822T (pt) | 2013-12-30 | 2022-05-06 | Atreca Inc | Análise de ácidos nucleicos associados com células isoladas usando códigos de barras de ácido nucleico |
| EP3957749A1 (en) | 2014-04-21 | 2022-02-23 | Natera, Inc. | Detecting tumour specific mutations in biopsies with whole exome sequencing and in cell-free samples |
| US12492429B2 (en) | 2014-04-21 | 2025-12-09 | Natera, Inc. | Detecting mutations and ploidy in chromosomal segments |
| US20180173846A1 (en) | 2014-06-05 | 2018-06-21 | Natera, Inc. | Systems and Methods for Detection of Aneuploidy |
| GB201411567D0 (en) | 2014-06-30 | 2014-08-13 | Epistem Ltd | Quantification methods |
| KR102295290B1 (ko) * | 2014-07-10 | 2021-08-30 | 플루어레센트릭 인코포레이티드 | Dna 증폭 기술 |
| CA2956174A1 (en) * | 2014-07-24 | 2016-01-28 | Brandeis University | Linear-expo-linear pcr (lel-pcr) |
| US9708647B2 (en) | 2015-03-23 | 2017-07-18 | Insilixa, Inc. | Multiplexed analysis of nucleic acid hybridization thermodynamics using integrated arrays |
| US11479812B2 (en) | 2015-05-11 | 2022-10-25 | Natera, Inc. | Methods and compositions for determining ploidy |
| HUE048349T2 (hu) * | 2015-05-18 | 2020-07-28 | Saga Diagnostics Ab | Célnukleinsavak és variánsok detektálása |
| US9499861B1 (en) | 2015-09-10 | 2016-11-22 | Insilixa, Inc. | Methods and systems for multiplex quantitative nucleic acid amplification |
| EP3347714B1 (en) * | 2015-09-10 | 2021-03-10 | InSilixa Inc. | Methods for multiplex quantitative nucleic acid amplification |
| WO2017087942A1 (en) | 2015-11-20 | 2017-05-26 | Brandeis University | Amplifying and detecting rna and dna sequences comprising high levels of intramolecular hybridization |
| WO2017155858A1 (en) | 2016-03-07 | 2017-09-14 | Insilixa, Inc. | Nucleic acid sequence identification using solid-phase cyclic single base extension |
| US11542547B2 (en) | 2016-04-07 | 2023-01-03 | Rutgers, The State University Of New Jersey | Multiplex nucleic acid assay methods capable of detecting closely related alleles, and reagents therefor |
| JP7280044B2 (ja) | 2016-04-15 | 2023-05-23 | ナテラ， インコーポレイテッド | 肺癌の検出方法 |
| WO2018067517A1 (en) | 2016-10-04 | 2018-04-12 | Natera, Inc. | Methods for characterizing copy number variation using proximity-litigation sequencing |
| GB201618485D0 (en) | 2016-11-02 | 2016-12-14 | Ucl Business Plc | Method of detecting tumour recurrence |
| US10011870B2 (en) | 2016-12-07 | 2018-07-03 | Natera, Inc. | Compositions and methods for identifying nucleic acid molecules |
| US10426424B2 (en) | 2017-11-21 | 2019-10-01 | General Electric Company | System and method for generating and performing imaging protocol simulations |
| WO2019118926A1 (en) | 2017-12-14 | 2019-06-20 | Tai Diagnostics, Inc. | Assessing graft suitability for transplantation |
| US12024738B2 (en) | 2018-04-14 | 2024-07-02 | Natera, Inc. | Methods for cancer detection and monitoring |
| EP3802857A4 (en) * | 2018-06-07 | 2022-03-09 | BioFire Diagnostics, LLC | RAPID THERMOCYCLING PROCESSES |
| US12234509B2 (en) | 2018-07-03 | 2025-02-25 | Natera, Inc. | Methods for detection of donor-derived cell-free DNA |
| EP3937780A4 (en) | 2019-03-14 | 2022-12-07 | InSilixa, Inc. | METHODS AND SYSTEMS FOR TIMED FLUORESCENCE-BASED DETECTION |
| WO2020247263A1 (en) | 2019-06-06 | 2020-12-10 | Natera, Inc. | Methods for detecting immune cell dna and monitoring immune system |
| CN114555829A (zh) | 2019-10-02 | 2022-05-27 | 新泽西鲁特格斯州立大学 | 检测稀有序列变体的测定方法和试剂盒 |
| CN112335926B (zh) | 2020-11-30 | 2025-03-11 | 厦门烟草工业有限责任公司 | 烟草加香机 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4965188A (en) | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
| US5066584A (en) | 1988-09-23 | 1991-11-19 | Cetus Corporation | Methods for generating single stranded dna by the polymerase chain reaction |
| US5210015A (en) | 1990-08-06 | 1993-05-11 | Hoffman-La Roche Inc. | Homogeneous assay system using the nuclease activity of a nucleic acid polymerase |
| US5994056A (en) | 1991-05-02 | 1999-11-30 | Roche Molecular Systems, Inc. | Homogeneous methods for nucleic acid amplification and detection |
| US5925517A (en) | 1993-11-12 | 1999-07-20 | The Public Health Research Institute Of The City Of New York, Inc. | Detectably labeled dual conformation oligonucleotide probes, assays and kits |
| US5538848A (en) | 1994-11-16 | 1996-07-23 | Applied Biosystems Division, Perkin-Elmer Corp. | Method for detecting nucleic acid amplification using self-quenching fluorescence probe |
| US5627054A (en) | 1996-04-05 | 1997-05-06 | The United States Of America As Represented By The Secretary Of The Army | Competitor primer asymmetric polymerase chain reaction |
| US5849497A (en) * | 1997-04-03 | 1998-12-15 | The Research Foundation Of State University Of New York | Specific inhibition of the polymerase chain reaction using a non-extendable oligonucleotide blocker |
| US6333179B1 (en) | 1997-06-20 | 2001-12-25 | Affymetrix, Inc. | Methods and compositions for multiplex amplification of nucleic acids |
| US6391544B1 (en) * | 1998-05-15 | 2002-05-21 | Abbott Laboratories | Method for using unequal primer concentrations for generating nucleic acid amplification products |
| US6277607B1 (en) | 1999-05-24 | 2001-08-21 | Sanjay Tyagi | High specificity primers, amplification methods and kits |
| AU2001250937A1 (en) * | 2000-03-22 | 2001-10-03 | Quantum Dot Corporation | Loop probe hybridization assay for polynucleotide analysis |
| US6887664B2 (en) | 2000-06-06 | 2005-05-03 | Applera Corporation | Asynchronous primed PCR |
-
2002
- 2002-12-17 US US10/320,893 patent/US7198897B2/en not_active Expired - Lifetime
- 2002-12-19 PT PT02795963T patent/PT1468114E/pt unknown
- 2002-12-19 CA CA2511128A patent/CA2511128C/en not_active Expired - Fee Related
- 2002-12-19 AU AU2002360685A patent/AU2002360685A1/en not_active Abandoned
- 2002-12-19 ES ES02795963T patent/ES2306807T3/es not_active Expired - Lifetime
- 2002-12-19 JP JP2003554933A patent/JP4355211B2/ja not_active Expired - Fee Related
- 2002-12-19 DK DK02795963T patent/DK1468114T3/da active
- 2002-12-19 DE DE60226500T patent/DE60226500D1/de not_active Expired - Lifetime
- 2002-12-19 WO PCT/US2002/040752 patent/WO2003054233A1/en not_active Ceased
- 2002-12-19 EP EP02795963A patent/EP1468114B1/en not_active Expired - Lifetime
- 2002-12-19 AT AT02795963T patent/ATE394508T1/de active
-
2007
- 2007-02-02 US US11/701,428 patent/US8367325B2/en active Active
-
2013
- 2013-01-04 US US13/734,684 patent/US9476092B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ATE394508T1 (de) | 2008-05-15 |
| EP1468114A1 (en) | 2004-10-20 |
| EP1468114A4 (en) | 2005-05-25 |
| US9476092B2 (en) | 2016-10-25 |
| DE60226500D1 (en) | 2008-06-19 |
| US20080280292A1 (en) | 2008-11-13 |
| US7198897B2 (en) | 2007-04-03 |
| US20040053254A1 (en) | 2004-03-18 |
| CA2511128A1 (en) | 2003-07-03 |
| PT1468114E (pt) | 2008-08-19 |
| WO2003054233A1 (en) | 2003-07-03 |
| US20130210656A1 (en) | 2013-08-15 |
| AU2002360685A1 (en) | 2003-07-09 |
| JP4355211B2 (ja) | 2009-10-28 |
| DK1468114T3 (da) | 2008-09-01 |
| HK1120088A1 (en) | 2009-03-20 |
| JP2005512577A (ja) | 2005-05-12 |
| US8367325B2 (en) | 2013-02-05 |
| EP1468114B1 (en) | 2008-05-07 |
| ES2306807T3 (es) | 2008-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2511128C (en) | Late-pcr | |
| JP7063886B2 (ja) | マルチプレックスリアルタイムｐｃｒを実施する方法 | |
| EP2534263B1 (en) | Methods and compositions for universal detection of nucleic acids | |
| WO2010065470A2 (en) | Compositions and methods for detecting background male dna during fetal sex determination | |
| JP2011530301A (ja) | プルーフリーディング・プライマー伸長 | |
| JPWO2010001969A1 (ja) | 標的核酸配列の増幅方法、それを用いた変異の検出方法、および、それに用いる試薬 | |
| JP2005531314A (ja) | 配列の相違を検出する方法 | |
| WO2010066407A1 (en) | Nuclease-free real-time detection of nucleic acids | |
| Pierce et al. | Linear-after-the-exponential polymerase chain reaction and allied technologies: Real-time detection strategies for rapid, reliable diagnosis from single cells | |
| EP3080297B1 (en) | Detecting single nucleotide polymorphism using hydrolysis probes with 3' hairpin structure | |
| EP3224375B1 (en) | Detecting single nucleotide polymorphism using overlapping hydrolysis probes | |
| EP1942196B1 (en) | Late-PCR | |
| Zhussupova | PCR–diagnostics | |
| JP5774990B2 (ja) | 蛍光標識及び可溶性消光体を使用する標的変異体の検出 | |
| Class et al. | Assignees: Brandeis University | |
| Pierce et al. | LATE-PCR and allied technologies: real-time detection strategies for rapid, reliable diagnosis from single cells | |
| HK1120088B (en) | Late-pcr | |
| EP2495335B1 (en) | Probe for detecting polymorphism in egfr genes, and usage therefor | |
| Kruse et al. | Molecular analysis of cytokines and cytokine receptors | |
| WO2010008809A2 (en) | Compositions and methods for early stage sex determination |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20181219 |